The short answer
Fish oil has not been shown to increase bleeding with zanubrutinib in a direct clinical study. Have the product reviewed, especially with low platelets, but a blanket avoidance or spacing rule is not supported by the evidence checked.
What this answer covers
EPA/DHA fish-oil products with oral zanubrutinib. Pure prescription EPA, other omega-3 formulations and food are separate exposures.
- Supplement or preparation
- Fish Oil
- Medication ingredient
- zanubrutinib
Check the prescribed treatment
This review concerns oral zanubrutinib in BRUKINSA capsules or tablets for selected blood cancers. Follow the exact product’s instructions and blood-count monitoring plan. The medicine can cause bleeding, but a drug warning alone does not prove that every supplement adds to that risk.
A large trial measured actual bleeding
In more than 1,500 cardiac-surgery patients, a short EPA/DHA fish-oil regimen did not increase major perioperative bleeding compared with placebo. It also reduced transfusion requirements. This was a clinical bleeding study, not just a platelet test, but it did not involve zanubrutinib.
Do not generalize across all products or patients
The trial’s EPA/DHA mixture and perioperative regimen do not establish the effects of every fish-oil supplement, purified EPA product or long-term high dose. Patients with severe treatment-related thrombocytopenia were not the specific population studied. Read the actual EPA and DHA amounts rather than only total oil weight.
Make changes with the treatment team
Tell the oncology team why you use fish oil and whether it is prescribed. They can assess the benefit against your platelet count, bleeding history and other medicines. No validated time gap was identified for this combination; report unusual bleeding and do not change the cancer-drug dose yourself.
Evidence and practical considerations
Side effects & toxicity
A large original EPA/DHA trial did not increase major bleeding; this limits generic fish-oil bleeding claims without proving safety during the exact cancer treatment.
- Exact scope
- EPA/DHA fish-oil products with oral zanubrutinib. Pure prescription EPA, other omega-3 formulations and food are separate exposures. with RxNorm 2262435 IN zanubrutinib. Exact current oral product: BRUKINSA oral zanubrutinib capsules and tablets. Salt, formulation and regimen distinctions explicit.
- Medication form and route
- Oral
What remains uncertain
- No exact drug-fish-oil trial. Original EPA/DHA clinical null does not establish universal safety, purified-EPA equivalence or safety in severe thrombocytopenia.
Factors that may matter: Exact oral formulation and supplement preparation; Drug exposure versus clinical outcomes; Dose and duration; Platelet count and neurological symptoms.
Read the supporting source summaries
Source 1: Current original prescribing information
dailymed.nlm.nih.gov · Source check Sep 11, 2026
Population: Patients prescribed the exact oral formulation.
Bleeding and cytopenia warnings; CYP3A inhibitor/inducer effects. Named citrus guidance separately sourced to capsule information.
How this applies: RxNorm 2262435 IN zanubrutinib. Exact current oral product: BRUKINSA oral zanubrutinib capsules and tablets. Salt, formulation and regimen distinctions explicit.
Exact product source, not a direct study of every supplement. Population, active metabolites and formulation scope retained.
Source 2: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 11, 2026
Population: 1516 patients undergoing cardiac surgery.
No higher major perioperative bleeding; fewer transfused units.
How this applies: Exact preparation/population/endpoints only; applicability to zanubrutinib independently assessed.
Abstract-only cardiac surgery, not target cancer-drug co-use or all omega-3 forms/durations; not proof of safety in severe thrombocytopenia.
Source 3: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 11, 2026
Population: Terminology.
zanubrutinib is IN.
How this applies: Exact ingredient.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Sources checked and article drafted. |
Article revision: d9f11ba7439ecc02
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.